Journal of the Korean Association of Oral and Maxillofacial Surgeons

The Korean Association of Oral and Maxillofacial Surgeons (대한구강악안면외과학회)
권호 표지

MAXILLARY MALIGNANT TUMORS : A RETROSPECTIVE STUDY

상악의 악성 종양에 관한 후향적 연구

  • Choi, Jong-Myung (Department of Oral and Maxillofacial Surgery, College of Dentistry, Yonsei University) ;
  • Choi, Se-Kyung (Department of Oral and Maxillofacial Surgery, College of Dentistry, Yonsei University) ;
  • Kim, Jae-Young (Department of Oral and Maxillofacial Surgery, College of Dentistry, Yonsei University) ;
  • Kim, Hyung-Jun (Department of Oral and Maxillofacial Surgery, College of Dentistry, Yonsei University) ;
  • Cha, In-Ho (Department of Oral and Maxillofacial Surgery, College of Dentistry, Yonsei University) ;
  • Nam, Woong (Department of Oral and Maxillofacial Surgery, College of Dentistry, Yonsei University)
  • 최종명 (연세대학교 치과대학 구강악안면외과학교실) ;
  • 최세경 (연세대학교 치과대학 구강악안면외과학교실) ;
  • 김재영 (연세대학교 치과대학 구강악안면외과학교실) ;
  • 김형준 (연세대학교 치과대학 구강악안면외과학교실) ;
  • 차인호 (연세대학교 치과대학 구강악안면외과학교실) ;
  • 남웅 (연세대학교 치과대학 구강악안면외과학교실)
  • Published : 2009.10.30
Download PDF
⟨ Previous Next ⟩

Abstract

Introduction: Maxillary malignant tumors are primary tumors of the maxillary gingiva, sinus, and palate. The purpose of this study was to research the prognosis and treatment modalities of maxillary malignant tumors. Materials & Methods: For this study, 52 patients, who were treated after being diagnosed for maxillary malignant tumors at the department of OMFS at Yonsei University college of Dentistry from January 1997 till April 2008, were classified, then the prognoses of these patients were evaluated depending on their primary site, histopathology and treatment modalities. The results of this study showed that the most common primary site for maxillary malignant tumors was the gingiva and for histopathology, squamous cell carcinoma. Result & Conclusion: The average follow up period was 32.7 months. In determining prognosis, the most important factors were the control of local site and metastasis of cervical lymph nodes. Therefore, for a better prognosis, a tumor free margin during surgery and a periodic follow up to examine for metastasis to cervical lymph nodes and other organs are necessary.

Keywords

References

  1. Bartkowski SB, Stypulkowska J, Stachura J, Panas M, Chrzastowska A, Gebczynski K, et al. Malignant tumours of the maxilla. Management and follow-up results of treatment of 128 patients. J Maxillofac Surg 1986;14:332-7 https://doi.org/10.1016/S0301-0503(86)80319-8
  2. Lindeman P, Eklund U, Petruson B. Survival after surgical treatment in maxillary neoplasms of epithelial origin. J Laryngol Otol 1987;101:564-8 https://doi.org/10.1017/S0022215100102257
  3. Zaharia M, Salem LE, Travezan R, Moscol A, Pinillos L, Farias C. Postoperative radiotherapy in the management of cancer of the maxillary sinus. Int J Radiat Oncol Biol Phys 1989;17:967-71 https://doi.org/10.1016/0360-3016(89)90143-0
  4. American Joint Committee on Cancer ; editors FLGea. AJCC cancer staging atlas. New York, Springer, 2006. pp.11-74
  5. Chidzonga MM. Oral malignant neoplasia: a survey of 428 cases in two Zimbabwean hospitals. Oral Oncol 2006;42:177-83 https://doi.org/10.1016/j.oraloncology.2005.07.003
  6. Parkin DM, Laara E, Muir CS. Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 1988;41:184-97 https://doi.org/10.1002/ijc.2910410205
  7. Shah JP. Head and neck surgery and oncology 3rd ed. London, Mosby, 2003. pp.353-8
  8. Baek JY, Choi SW, Lee EW, Choi EC, Cha IH. A Clinical Study of Malignant Tumors of the Maxilla. J Korean Assoc Oral Maxillofac Surg. 2000;26:391-5
  9. Neville BW. Oral & maxillofacial pathology 2nd ed. Philadelphia, W.B. Saunders, 2002. pp.356-67, 376-80, 420-8, 480-7
  10. Ajayi OF, Adeyemo WL, Ladeinde AL, Ogunlewe MO, Effiom OA, Omitola OG, et al. Primary malignant neoplasms of orofacial origin: a retrospective review of 256 cases in a Nigerian tertiary hospital. Int J Oral Maxillofac Surg 2007;36:403-8 https://doi.org/10.1016/j.ijom.2007.01.007
  11. Binahmed A, Nason RW, Hussain A, Abdoh AA, Sandor GK. Treatment outcomes in squamous cell carcinoma of the maxillary alveolus and palate: a population-based study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;105:750-4. https://doi.org/10.1016/j.tripleo.2007.09.001
  12. Simental AA, Jr., Johnson JT, Myers EN. Cervical metastasis from squamous cell carcinoma of the maxillary alveolus and hard palate. Laryngoscope 2006;116:1682-4 https://doi.org/10.1097/01.mlg.0000233607.41540.28
  13. Montes DM, Schmidt BL. Oral maxillary squamous cell carcinoma: management of the clinically negative neck. J Oral Maxillofac Surg 2008;66:762-6 https://doi.org/10.1016/j.joms.2007.12.017
  14. Yorozu A, Sykes AJ, Slevin NJ. Carcinoma of the hard palate treated with radiotherapy: a retrospective review of 31 cases. Oral Oncol 2001;37:493-7 https://doi.org/10.1016/S1368-8375(00)00136-6
  15. Haddadin KJ, Soutar DS, Oliver RJ, Webster MH, Robertson AG, MacDonald DG. Improved survival for patients with clinically T1/T2, N0 tongue tumors undergoing a prophylactic neck dissection. Head Neck 1999;21:517-25 https://doi.org/10.1002/(SICI)1097-0347(199909)21:6<517::AID-HED4>3.0.CO;2-C
  16. Kruse AL, Gratz KW. Cervical metastases of squamous cell carcinoma of the maxilla: a retrospective study of 9 years. Head Neck Oncol 2009;1:28 https://doi.org/10.1186/1758-3284-1-28